Sector
PharmaceuticalsOpen
₹345Prev. Close
₹340.55Turnover(Lac.)
₹0.46Day's High
₹345Day's Low
₹33652 Week's High
₹052 Week's Low
₹0Book Value
₹5.52Face Value
₹10Mkt Cap (₹ Cr.)
342.43P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 10.02 | 10.02 | 10.02 | 10.02 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -4.48 | -0.15 | -4.62 | -18.19 |
Net Worth | 5.54 | 9.87 | 5.4 | -8.17 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 85.11 | 44.34 | 32.8 | 18.09 |
yoy growth (%) | 91.9 | 35.2 | 81.24 | -38.59 |
Raw materials | -35.94 | -18.37 | -13.78 | -8.88 |
As % of sales | 42.23 | 41.44 | 42.01 | 49.09 |
Employee costs | -27.68 | -17.98 | -15.02 | -12.88 |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | -3.62 | -9.69 | -10.85 | -17.94 |
Depreciation | -7.23 | -3.54 | -3.63 | -3.86 |
Tax paid | 0.56 | -0.09 | 1.21 | 1.2 |
Working capital | -43.52 | -22.64 | -8.91 | -7.43 |
Other operating items |
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 91.9 | 35.2 | 81.24 | -38.59 |
Op profit growth | -146.32 | -18.57 | -45.62 | 575.88 |
EBIT growth | -80.55 | -10.76 | -42.57 | 212.45 |
Net profit growth | -68.72 | 15.74 | -44.09 | 145.85 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
S T R Mady
Non-Exec & Non-Independent Dir
S Jayaprakash Mady
Vice President & CS
B P Thyagaraj
Non-Exec. & Independent Dir.
R A Thirumoorti
Non-Exec. & Independent Dir.
K Paranjothy
Addtnl Non-Exe Dir &Indpnt Dir
S Nanthitha
Additional Director
Arshad Kagalwalla
54/1 Boodihal Village,
Nelamangala,
Karnataka - 562123
Tel: 91-80-27733370-67086500
Website: http://www.somersetlimited.com
Email: thyagaraj@wintaclimited.com
J P Royale I Floor,
No.218 Sampige Road, Malleswaram,
Bangalore - 560003
Tel: 91-080-23469661/62,
Website: www.canbankrta.com
Email: ccslrnt@vsnl.com/ccslrnt@eth.net
Summary
Wintac Ltd is a pharmaceutical company based in Bangalore. The company is engaged in development, manufacturing and marketing of quality pharmaceutical products. Their primary business activity compri...
Read More
Reports by Somerset Therapeutics Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.